MSI Statement on U.S. Supreme Court Hearing on Mifepristone

Policy and advocacy   |   26 March 2024   |   3 min read

Share






Copied


MSI comment on leaked Roe vs. Wade Supreme Court document

Tuesday 26th March 2024 – Today, the Supreme Court of the United States will hear oral arguments around access to mifepristone, an essential abortion medication that is used by more than 5 million people in the U.S. and has been approved by the Food and Drug Administration (FDA) for more than 20 years.

Oral arguments for U.S. Food and Drug Administration v. Alliance for Hippocratic Medicine come after various U.S. lower court rulings limiting access to mifepristone. Last year, the Supreme Court issued a stay ruling on the case, meaning mifepristone is still accessible while the Supreme Court makes a final decision, which is expected in June. 

Dr. Dhammika Perera, MSI Reproductive Choices’ Global Medical Director said:  

“Mifepristone is used in over half of U.S. abortions and restricting its availability threatens reproductive choice for all Americans. As one of the world’s leading providers of comprehensive abortion care, we recognize that reliable delivery of reproductive healthcare can transform women’s lives. Access to the effective combination regimen of mifepristone and misoprostol is essential to ensuring women and girls have the power to determine their own futures. In addition to accessing mifepristone in a clinic setting, we’re seeing that self-managed medication abortion is often preferred among our clients, especially those who struggle to reach a provider in person. Globally, mifepristone is approved and has been used safely and effectively in over 90 countries for over 30 years. Our work to help people around the world access the abortion care they need has made it clear that access to mifepristone is critical to expanding and protecting reproductive choice. 

“The fact that access to mifepristone is even being questioned in the United States shows a dangerous and continuous rollback of reproductive rights in the country, especially as we approach the two-year mark of Roe v. Wade being overturned. While so many other nations across the world are making progress to protect reproductive freedom and abortion care, the United States is moving backward. We believe in a world where everyone has the right to decide their own futures without fear of stigma or legal consequences.”


Notes to Editor 

For interviews and further information please contact: 

Email: press@msichoices.org  

Tel: +44 (0)7769 166 516  


Share






Copied

Related posts

News


10 January 2024   |   3 min read

MSI launches the Every Choice campaign

We live in a world of seemingly infinite choice. However, for half of the global population, one of the most

News


15 January 2024   |   2 min read

Help protect UK abortion clinics with Safe Access Zones

Use MSI’s guide to have your say on UK abortion clinic Safe Access Zones. Join our fight so people can access

News


13 December 2023   |   2 min read

MSI at the 2023 Ouagadougou Partnership Annual Meeting

This week, MSI Reproductive Choices is proud to be at the 2023 Ouagadougou Partnership Annual Meeting in Abidjan.